Walgreens Boots Alliance (WBA) Given New $75.00 Price Target at SunTrust Banks
Walgreens Boots Alliance (NASDAQ:WBA) had its price objective hoisted by SunTrust Banks to $75.00 in a research note released on Friday, The Fly reports. SunTrust Banks currently has a hold rating on the pharmacy operator’s stock. SunTrust Banks also issued estimates for Walgreens Boots Alliance’s Q1 2019 earnings at $1.49 EPS, Q2 2019 earnings at $1.73 EPS, Q3 2019 earnings at $1.68 EPS, FY2019 earnings at $6.50 EPS and FY2020 earnings at $7.00 EPS.
WBA has been the subject of a number of other reports. Loop Capital raised their price target on Walgreens Boots Alliance to $80.00 and gave the stock a buy rating in a research note on Friday, June 29th. Pivotal Research lowered their price objective on Walgreens Boots Alliance from $70.00 to $60.00 and set a hold rating for the company in a research report on Monday, July 2nd. Mizuho cut Walgreens Boots Alliance from a buy rating to a neutral rating and set a $64.00 price target on the stock. in a research note on Monday, July 2nd. BidaskClub upgraded Walgreens Boots Alliance from a strong sell rating to a sell rating in a research note on Saturday, June 16th. Finally, TheStreet upgraded Walgreens Boots Alliance from a c+ rating to a b rating in a research note on Wednesday, September 12th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $77.56.
Shares of Walgreens Boots Alliance stock traded up $2.60 on Friday, reaching $73.50. The company had a trading volume of 9,645,179 shares, compared to its average volume of 6,227,956. The stock has a market cap of $72.35 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 1.11 and a beta of 1.04. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.47 and a current ratio of 0.93. Walgreens Boots Alliance has a 1 year low of $59.07 and a 1 year high of $80.68.
In related news, COO Ornella Barra acquired 1,700,000 shares of Walgreens Boots Alliance stock in a transaction dated Monday, July 16th. The shares were acquired at an average cost of $65.15 per share, for a total transaction of $110,755,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total value of $180,548.64. Following the completion of the sale, the director now owns 10,943 shares in the company, valued at $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by company insiders.
A number of institutional investors have recently bought and sold shares of the business. Livingston Group Asset Management CO operating as Southport Capital Management acquired a new stake in Walgreens Boots Alliance in the third quarter valued at $154,000. Bank of Montreal Can raised its stake in Walgreens Boots Alliance by 17.5% in the third quarter. Bank of Montreal Can now owns 1,941,036 shares of the pharmacy operator’s stock valued at $141,502,000 after buying an additional 288,921 shares in the last quarter. Busey Trust CO raised its stake in Walgreens Boots Alliance by 8.1% in the third quarter. Busey Trust CO now owns 10,824 shares of the pharmacy operator’s stock valued at $789,000 after buying an additional 812 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in Walgreens Boots Alliance by 10.1% in the third quarter. Parkside Financial Bank & Trust now owns 7,649 shares of the pharmacy operator’s stock valued at $557,000 after buying an additional 703 shares in the last quarter. Finally, Pittenger & Anderson Inc. raised its stake in Walgreens Boots Alliance by 82.9% in the third quarter. Pittenger & Anderson Inc. now owns 27,280 shares of the pharmacy operator’s stock valued at $1,989,000 after buying an additional 12,365 shares in the last quarter. Institutional investors own 61.92% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Recommended Story: Intrinsic Value
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.